Karzai W, Lötte A, Günnicker M, Vorgrimler-Karzai U M, Priebe H J
Department of Anaesthesiology, University Hospital of Freiburg, Germany.
Br J Anaesth. 1996 Jan;76(1):5-8. doi: 10.1093/bja/76.1.5.
We have studied the effects of flow and dobutamine on systemic haemodynamic variables, oxygen delivery (DO2) and oxygen consumption (VO2) in 20 patients during cardiopulmonary bypass (CPB) with mild hypothermia (34 degrees C). In a subgroup of seven patients, we also studied the effects on gastric microcirculatory blood flow (MCF) using laser Doppler flowmetry. During CPB, measurements were made before and after two interventions: the first consisted of increasing flow from 2.4 to 3.0 litre min-1 m-2 for 10 min; the second consisted of an infusion of dobutamine at a rate of 6 micrograms kg-1 min-1 for 10 min during constant flow CPB. There were no significant differences in DO2, VO2 or haemodynamic variables between the two baseline measurements. The increase in flow raised DO2 (27%, P < 0.001), mean arterial pressure (P < 0.01) and MCF (P < 0.01), but failed to increase VO2. In contrast, dobutamine infusion increased VO2 (11%, P < 0.001) during constant flow CPB without significant changes in DO2, systemic haemodynamic variables or MCF. These results indicate that increases in VO2 during dobutamine may be flow-independent.
我们研究了在轻度低温(34摄氏度)体外循环(CPB)期间,流量和多巴酚丁胺对20例患者全身血流动力学变量、氧输送(DO2)和氧消耗(VO2)的影响。在一个由7名患者组成的亚组中,我们还使用激光多普勒血流仪研究了其对胃微循环血流量(MCF)的影响。在CPB期间,在两种干预前后进行测量:第一种干预是将流量从2.4升·分钟-1·米-2增加到3.0升·分钟-1·米-2,持续10分钟;第二种干预是在恒定流量CPB期间,以6微克·千克-1·分钟-1的速率输注多巴酚丁胺,持续10分钟。两次基线测量之间的DO2、VO2或血流动力学变量没有显著差异。流量增加使DO2升高(27%,P<0.001)、平均动脉压升高(P<0.01)和MCF升高(P<0.01),但未能增加VO2。相比之下,在恒定流量CPB期间,输注多巴酚丁胺使VO2升高(11%,P<0.001),而DO2、全身血流动力学变量或MCF没有显著变化。这些结果表明,多巴酚丁胺期间VO2的增加可能与流量无关。